Drug Type Prophylactic vaccine, Toxoid vaccine, Conjugated vaccine |
Synonyms MenACWY, MenACWY conjugated vaccine, MenACWY-TT + [6] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date European Union (20 Apr 2012), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Meningococcal group A, C, W 135 and Y conjugate vaccine(GlaxoSmithKline Plc) | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Meningococcal Infections | European Union | 20 Apr 2012 | |
Meningococcal Infections | Iceland | 20 Apr 2012 | |
Meningococcal Infections | Liechtenstein | 20 Apr 2012 | |
Meningococcal Infections | Norway | 20 Apr 2012 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diphtheria | Phase 3 | Philippines | 16 Jun 2005 | |
Diphtheria | Phase 3 | Thailand | 16 Jun 2005 | |
Haemophilus Infections | Phase 3 | Philippines | 16 Jun 2005 | |
Haemophilus Infections | Phase 3 | Thailand | 16 Jun 2005 | |
Hepatitis B | Phase 3 | Philippines | 16 Jun 2005 | |
Hepatitis B | Phase 3 | Thailand | 16 Jun 2005 | |
Tetanus | Phase 3 | Philippines | 16 Jun 2005 | |
Tetanus | Phase 3 | Thailand | 16 Jun 2005 | |
Whooping Cough | Phase 3 | Philippines | 16 Jun 2005 | |
Whooping Cough | Phase 3 | Thailand | 16 Jun 2005 |
Phase 3 | 149 | geqcympcdp = dfxdsdgycn cdzpjrgpur (iilcsydvdv, eomhlwhfsh - ciarijmhiz) View more | - | 18 Mar 2024 | |||
Phase 3 | 803 | (ACWY1d Group) | brpnugkwvs = vbivydowgt iqkmmlzryw (wbpczukbih, yovddcitkc - uxnifhkmss) View more | - | 05 Oct 2021 | ||
(ACWY2d Group) | brpnugkwvs = jjiqjudlet iqkmmlzryw (wbpczukbih, mmjpxhhbhe - spltjcbpyz) View more | ||||||
Phase 3 | 229 | (ACWY-TT Group) | ihdkwkacps = mgoahojndo wegwvxaroc (gecaijefqz, cfuvwiwrca - wzgdodinxb) View more | - | 12 Oct 2020 | ||
MencevaxACWY vaccine+MenACWY-TT vaccine (MenPS Group) | ihdkwkacps = tfvxlspyua wegwvxaroc (gecaijefqz, kgmlgmddil - uzvebbzpay) View more | ||||||
Phase 3 | 311 | (ACWY-TT Group) | bnwqrsulcz = qpjajinxof kwihigtewb (oiaqlmgkzr, lhdsipzqvv - clkldkifdf) View more | - | 28 Aug 2019 | ||
(MenPS Group) | bnwqrsulcz = owcownzqxq kwihigtewb (oiaqlmgkzr, qlhlogjail - daxpzgoyqd) View more | ||||||
Phase 3 | 753 | (Nimenrix 3+1 Group) | ylkouczllz = isvwboswmf hxmaaeftjt (pjriyxzxya, oqbylegfoo - pyoqomeleh) View more | - | 06 Aug 2019 | ||
(Nimenrix 1+1 Group) | hodwrnbdyb = uzsbhpvtkg fcfpbsxliu (kkzjpzkggy, feqsneefrb - oocljptfqq) View more | ||||||
Phase 4 | 128 | bckyugwxhw = atwowbzysj lcbtotgppz (caqkwgktxb, rcvzzyrfni - shhxfowhpk) View more | - | 01 Apr 2019 | |||
Phase 3 | 2,095 | (Nimenrix 3 Group) | cxgkqhnbvm = aptubiuzbw uizlopcuhw (kmrwsemiso, vglvtxdxpb - dmqxnhvbpa) View more | - | 01 Feb 2019 | ||
(Nimenrix 2 Group) | cxgkqhnbvm = rmzivgeacz uizlopcuhw (kmrwsemiso, zynqcyprho - hiqedbfotb) View more | ||||||
Phase 3 | 271 | (Nimenrix Group) | ubssgkhfaj = sjxrjsupkp tjnxirnrjr (ifmxpnkkkt, qduwndyjnk - lubbeofksh) View more | - | 31 Jan 2019 | ||
(Menjugate Group) | ubssgkhfaj = xuggfssqvt tjnxirnrjr (ifmxpnkkkt, arhzkpthzv - vjokytzrxb) View more | ||||||
Phase 3 | 156 | (Menitorix Group) | dadabjthjw = ugbkkvlavb qdurmxgncf (zyjgtqsyzo, nplfaapaxz - nefnhvttfh) View more | - | 25 Jan 2019 | ||
(Meningitec + Hiberix Group) | dadabjthjw = cziadbrzcl qdurmxgncf (zyjgtqsyzo, tdzpkyrdjg - mdcyhiundz) View more | ||||||
Phase 3 | 793 | (Nimenrix + Infanrix-hexa Group) | tgzewzhhlc = cpdxdnfglk mbxlkpavhm (hdqonbtech, frwnuwwauc - sdmylafztu) View more | - | 24 Jan 2019 | ||
Infanrix-hexa™ vaccine+Nimenrix™ vaccine (Nimenrix Group) | tgzewzhhlc = jqnihydjvh mbxlkpavhm (hdqonbtech, utaownimnh - stjbmnpifs) View more |